You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,057,305


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,057,305
Title: Antiretroviral enantiomeric nucleotide analogs
Abstract:Resolved enantiomers of the formula ##STR1## wherein B is a purine or pyrimidine base or aza and/or deaza analogs thereof are useful in antiviral pharmaceutical compositions to treat retroviral infections.
Inventor(s): Holy ; Antonin (Praha, CS), Dvorakova ; Hana (Praha, CS), DeClercq; Erik Desire Alice (Lovenjoel, BE), Balzarini; Jan Marie Rene (Heverlee, BE)
Assignee: Institute of Organic Chemistry and Biochemistry of the Academy of (CZ) Rega Stichting, v.z.w. (BE)
Application Number:07/925,610
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,057,305: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the intellectual property landscape effectively. This article will delve into the details of United States Patent 6,057,305, focusing on its scope, claims, and the broader patent landscape.

Overview of the Patent

Patent Title and Description

United States Patent 6,057,305, titled "Antiretroviral enantiomeric nucleotide analogs," pertains to a specific class of antiretroviral drugs. These drugs are designed to combat retroviruses, such as HIV, by inhibiting the reverse transcriptase enzyme, a critical component in the viral replication process[5].

Inventors and Assignees

The patent lists the inventors and the assignees, which are essential for understanding the ownership and rights associated with the patent. In this case, the inventors and assignees would be identified in the patent document, often including pharmaceutical companies or research institutions.

Scope of the Patent

Claims

The claims section of a patent is the most critical part, as it defines the scope of protection granted by the patent. For US Patent 6,057,305, the claims would outline the specific antiretroviral enantiomeric nucleotide analogs, their chemical structures, and any methods of use or manufacture. These claims must be carefully analyzed to understand what is protected and what is not[5].

Independent and Dependent Claims

Patents typically include both independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations. Understanding the hierarchy of claims is vital for determining the patent's overall scope.

Detailed Analysis of Claims

Chemical Structure and Composition

The patent would detail the specific chemical structures of the antiretroviral enantiomeric nucleotide analogs. This includes the molecular formula, stereochemistry, and any other relevant chemical characteristics. These details are crucial for distinguishing the patented compounds from other similar compounds.

Methods of Use and Manufacture

In addition to the chemical composition, the patent may claim specific methods of using these compounds, such as their application in treating HIV, and methods of manufacturing them. These method claims can be just as important as the composition claims, as they protect the process of creating and using the invention.

Patent Landscape

Prior Art and Citations

To understand the novelty and non-obviousness of the invention, it is essential to review the prior art cited in the patent. This includes other patents, publications, and any other relevant documents that were considered during the patent examination process. Tools like the Common Citation Document (CCD) can be useful in consolidating citation data from multiple patent offices[1].

Global Patent Family

The patent landscape extends beyond the U.S. patent. Using resources like the Global Dossier, one can identify related applications filed at participating IP Offices, including the IP5 Offices (the USPTO, EPO, JPO, KIPO, and CNIPA). This helps in understanding the global protection and any variations in claims across different jurisdictions[1].

International Patent Offices and Databases

European Patent Office (EPO) and Other International Databases

To see if similar patents exist abroad, one must search international patent databases such as the EPO's esp@cenet, the Japan Patent Office's database, and the World Intellectual Property Organization's (WIPO) PATENTSCOPE. These databases provide access to machine translations and full-text searches of international patent applications[1].

Economic and Research Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide insights into the trends and measurements of patent scope. This dataset, derived from patent application and grant full-text files, includes detailed information on claims and their dependency relationships. It can help in understanding the broader economic and research implications of patents in the antiretroviral drug sector[3].

Practical Applications and Impact

Use in HIV Treatment

The antiretroviral enantiomeric nucleotide analogs patented in US 6,057,305 are designed to prevent or treat HIV infections. Understanding the scope of this patent is crucial for pharmaceutical companies and researchers working on similar treatments to ensure they do not infringe on existing patents.

Future Research and Development

The patent's claims and scope can also guide future research and development in the field. By knowing what is already protected, researchers can focus on developing new compounds or methods that do not infringe on existing patents, thereby advancing the field without legal complications.

Key Takeaways

  • Understand the Claims: The claims section is the heart of any patent, defining what is protected.
  • Global Landscape: Use tools like the Global Dossier to understand the patent's global implications.
  • Prior Art: Review cited prior art to understand the novelty and non-obviousness of the invention.
  • International Databases: Search international patent databases to ensure global compliance.
  • Economic Implications: Utilize datasets like the Patent Claims Research Dataset to understand broader economic trends.

FAQs

Q: What is the main focus of United States Patent 6,057,305?

A: The main focus of US Patent 6,057,305 is on antiretroviral enantiomeric nucleotide analogs used to combat retroviruses like HIV.

Q: How do I determine the scope of protection for this patent?

A: The scope of protection is defined by the claims section of the patent, which includes both independent and dependent claims.

Q: What resources can I use to search for related international patents?

A: Resources like the Global Dossier, EPO's esp@cenet, JPO's database, and WIPO's PATENTSCOPE can be used to search for related international patents.

Q: Why is it important to review prior art cited in the patent?

A: Reviewing prior art helps in understanding the novelty and non-obviousness of the invention and ensures that the patented invention is distinct from existing knowledge.

Q: How can I use the Patent Claims Research Dataset in my analysis?

A: The Patent Claims Research Dataset provides detailed information on claims and their dependency relationships, helping in understanding trends and measurements of patent scope.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Canadian Patents Database - Patent 2570877 Summary: https://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/2570877/summary.html
  5. Google Patents - US6057305A: https://patents.google.com/patent/US6057305A/ko

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,057,305

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,057,305

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 179983 ⤷  Subscribe
Canada 2141589 ⤷  Subscribe
Canada 2574904 ⤷  Subscribe
Czech Republic 290797 ⤷  Subscribe
Czech Republic 293533 ⤷  Subscribe
Czech Republic 9500272 ⤷  Subscribe
Germany 69324923 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.